Cymipristone
赛米司酮
Report date: 2025/11/18 09:32:47
NME
Base Information
Drug NameCymipristone
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaPending
Originator CompaniesShanghai Zhongxi Sunve Pharmaceutical Co LtdShanghai Sanhe Bio-Technology Co LtdZhejiang Xianju Pharmaceutical Co Ltd +[4]
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesN/A
Inactive CompaniesZhejiang Xianju Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A